G35
Conditions
Interventions
Group 1: intervention group: hippotherapy (12 weeks, once a week for 30 minutes)
Group 2: control group (unchanged continuation of the physiotherapy according to the remedy guidelines
unchanged continuation of the pharmacotherapy)
Sponsors
Zentrum für Therapeutisches Reiten Johannisberg e.V.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Definite multiple sclerosis with spasticity of the lower limbs; EDSS-Score between 4 and 6.5; Presence of an informed consent form signed by the patient; Consent of the responsible investigator; Legal capacity; Minimum age of 18 years
Exclusion criteria
Exclusion criteria: Hippotherapy within the last 12 months; Parallel participation in other interventional studies; Persons, who have an employment relationship/ a relationship of dependency on the sponsor or the investigator Placing in an institution because of responsible governmental or judicial authorities; Body weight above 90 kg; Acute episode between 4 weeks prior to the start of the therapy; No balance while sitting; Planned start of an new spasmolytic drug or drugs, which could influence the tested parameters (for example Sativex®; Injection of Baclofen close to the spinal cord, 4-Aminopyridin); cerebral seizure disorder, that is not medically adjusted; No or insufficient ability to spread out the legs, which is necessary to sit on a horse; Heavy osteoporosis; Heavy arthrosis of the hip joint; Heavy scoliosis, which could deteriorate under hippotherapy; Heavy disorder of blood clotting, which increase the risk for bleedings because of hippotherapy Unstable internal, gynaecological, surgical secondary illness; Insurmountable fear of horses; Allergy against horsehair; Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in balance ability: Change of Berg-Balance-Scale (BBS) after 12 weeks of hippotherapy (relative to the initial value) | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in fatigue: Fatigue Severity Scale (FSS) after 12 weeks of hippotherapy (relative to the initial value); Change in quality of life: Multiple Sclerosis Quality of Life-54 (MSQOL-54) after 12 weeks of hippotherapy (relative to the initial value); Change in pain intensity: Visual Analogue Scale (VAS) after 12 weeks of hippotherapy (relative to the initial value); Change in spasticity: Numeric Rating-Scale (NRS) after 12 weeks of hippotherapy (relative to the initial value) | — |
Countries
Germany
Contacts
Public ContactMarion Drache
Zentrum für Therapeutisches Reiten Johannisberg e.V.
Outcome results
None listed